drugset / Trial / NCT00002767
Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
RandomizedTreatment
Summary
RATIONALE: Interferon alfa may interfere with the growth of cancer cells.Vaccines may make the body build an immune response to kill tumor cells. It is not yet known whether melanoma vaccine plus interferon alfa is more effective than interferon alfa alone in treating patients with metastatic melanoma. PURPOSE: Randomized phase III trial to compare the effectiveness of interferon alfa with or without vaccine therapy in treating patients with metastatic melanoma.
Timeline
- Start
- 1996-01
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Detox-B adjuvant | Unknown | — | Subcutaneous |
| Subject | interferon alfa-2b | Protein / enzyme biologic | — | Subcutaneous |